MADx ALEX3 Allergy Explorer
Allergen sensitization (IgE detection)
Approved/CommercialMarketed (Health Canada Licensed)
Key Facts
Indication
Allergen sensitization (IgE detection)
Phase
Approved/Commercial
Status
Marketed (Health Canada Licensed)
Company
About ALPCO Diagnostics
Founded in 1991 as the American Laboratory Products Company, ALPCO has evolved from a distributor into a leading global diagnostics firm. Its strategic merger with GeneProof in April 2022 significantly expanded its capabilities in molecular diagnostics. The company now provides integrated platforms for immunodiagnostics and PCR-based molecular diagnostics, serving clinical and research laboratories with high-quality, automated testing solutions.
View full company profileTherapeutic Areas
Other Allergen sensitization (IgE detection) Drugs
| Drug | Company | Phase |
|---|---|---|
| MADx ALEX2 Allergy Explorer | ALPCO Diagnostics | Approved/Commercial |